Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PGEN · against 427 other Healthcare companies of similar size
Ranked #306 of 428 · scores higher than 8% of peers
Bars: peers in each 10-point band of the valuation score123 peers with a valuation score of 0–9, including PGEN · Click a bar to see the companies
Mainly because of its earnings yield, EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | PGEN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 416 reported | -20.4% | 1.7% | 6% | 30% | |
| EBITDA yieldHigher is better · 427 reported | -2.0% | 4.5% | 24% | 50% | |
| Free cash flow yieldHigher is better · 193 reported | -6.1% | -0.5% | 30% | 20% | |
| Book yieldHigher is better · 418 reported | 2.3% | 35.9% | 7% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 306 | 1.6B USD | 8 | 30 | |
| 306 | 1.5B USD | 8 | 30 | |
| 306 | 1.3B USD | 8 | 20 | |
| 306 | 994M USD | 8 | 39 | |
| 306 | 1.9B USD | 8 | 32 | |
| 306 | 2.4B USD | 8 | ||
| 306 | 3.7B USD | 8 | 24 | |
| 306 | 1.1B USD | 8 | 46 | |
| 306 | 1.7B USD | 8 | 21 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score